MRI-guided biopsy for brain cancer improves diagnosis

Neurosurgeons at UC San Diego Heath System have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that increases the accuracy of diagnosis for patients with brain cancer.

"There are many different types of . Making an accurate diagnosis is paramount because the diagnosis dictates the subsequent course of treatment," said Clark C. Chen, MD, PhD, vice-chairman of research, division of neurosurgery, UC San Diego School of Medicine. "For instance, the treatment of glioblastoma is fundamentally different than the treatment for oligodendroglioma, another type of brain tumor."

Chen said that as many as one third of brain tumor biopsies performed in the traditional manner can result in misdiagnosis. He cited two challenges with conventional biopsy.

"First, because distinct areas of exhibit different cell densities and higher cell densities are generally associated with higher tumor grade, biopsies taken from one region may yield a different diagnosis than if another area is biopsied," said Chen. "Second, because tumors are hidden within the brain, surgeons must use mathematical algorithms to target where the biopsy should occur. As with all calculations, the process is subject to errors that the surgeon cannot easily correct in real time once the biopsy has begun."

Chen's team applied an MRI technique called Restriction Spectrum Imaging (RSI) to visualize the parts of the brain tumor that contain different cell densities.

This video is not supported by your browser at this time.

"RSI allows us to identify the regions of the cell that are most representative of the entire tumor," said Chen. "By targeting biopsies to these areas, we minimize the number of biopsies needed but still achieve a sampling that best characterizes the entire tumor."

To ensure a targeted biopsy, Chen performs the procedure in the MRI suite while the patient is under general anesthesia. Because conventional biopsy equipment cannot be used in the MRI, Chen uses a special MRI-compatible system called ClearPoint®. This system utilizes an integrated set of hardware, software, and surgical equipment to allow the surgeon to target and visualize the path of the biopsy as well as the actual biopsy site, intraoperatively.

"Surgeons have been performing biopsies in a near blind manner for the past fifty years. The ability to see where the is located and where the is being performed in real time is groundbreaking," said Chen. "This combination of technologies gives me an opportunity to immediately adjust my surgical approach while minimizing risk."

add to favorites email to friend print save as pdf

Related Stories

Brain surgeons go with the flow

Nov 22, 2013

(Medical Xpress)—Neurosurgeons at UC San Diego Health System are using a new approach to visualize the brain's delicate anatomy prior to surgery. The novel technique allows neurosurgeons to see the brain's ...

Surgical breast biopsy not overused, study suggests

Feb 01, 2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies are mo ...

Real-time MRI-guided gene therapy for brain cancer

Aug 07, 2013

Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance ...

Recommended for you

Same cancer, different time zone

14 hours ago

Just as no two people possess the same genetic makeup, a recent study has shown that no two single tumor cells in breast cancer patients have an identical genome.

User comments